References
- Svihrova V, Szilagyiova M, Waczulikova I, et al. The estimation of the economic burden of measles in terms of direct and indirect costs per case. Infect Dis (Lond). 2017. [Epub ahead of print]. doi: 10.1080/23744235.2017.1401734
- García Comas L, Ordobás Gavín M, Sanz Moreno JC, et al. Community-wide measles outbreak in the Region of Madrid, Spain, 10 years after the implementation of the Elimination Plan, 2011–2012. Hum Vaccin Immunother. 2017;13:1078–1083.
- Georgakopoulou T, Grylli C, Kalamara E, et al. Current measles outbreak in Greece. Euro Surveill. 2006;11:2906.
- Muscat M, Marinova L, Mankertz A, et al. The measles outbreak in Bulgaria, 2009–2011: an epidemiological assessment and lessons learnt. Euro Surveill. 2016;21:30152.
- Pervanidou D, Horefti E, Patrinos S, et al. Spotlight on measles 2010: ongoing measles outbreak in Greece, January-July 2010. Euro Surveill. 2010;15:19629.
- Filia A, Amendola A, Faccini M, et al. Outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016. Euro Surveill. 2016;21:30235.
- European Commission. COMMISSION IMPLEMENTING DECISION of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (notified under document C(2012) 5538) (Text with EEA relevance) (2012/506/EU). 18.06.2008:L 262.
- Carazo Perez S, De Serres G, Bureau A, et al. Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose. Clin Infect Dis. 2017;65:1094–1102.
- Giambi C, Fabiani M, D'Ancona F, et al. Parental vaccine hesitancy in Italy - results from a national survey. Vaccine. 2018;36:779–787.
- Shapiro GK, Tatar O, Dube E, et al. The vaccine hesitancy scale: psychometric properties and validation. Vaccine. 2018;36:660–667.